These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32251199)

  • 21. Visit-to-visit blood pressure variability and hip fracture risk in older persons.
    Li TC; Li CI; Liu CS; Lin WY; Lin CH; Yang SY; Chiang JH; Lin CC
    Osteoporos Int; 2019 Apr; 30(4):763-770. PubMed ID: 30789999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visit-to-visit SBP variability and cardiovascular disease in a multiethnic primary care setting: 10-year retrospective cohort study.
    Chia YC; Ching SM; Lim HM
    J Hypertens; 2017 May; 35 Suppl 1():S50-S56. PubMed ID: 28350621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.
    Contreras G; Lu L; Tamariz L; Rocco MV; Papademetriou V; Kostis JB; Pisoni R; Glasser SP; Sweeney ME; Basile J; Gren LH; Zamanian S; Cushman WC;
    J Hypertens; 2020 Aug; 38(8):1567-1577. PubMed ID: 32371767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Hypertension; 2017 Dec; 70(6):1273-1282. PubMed ID: 29038204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).
    Imai E; Ito S; Haneda M; Harada A; Kobayashi F; Yamasaki T; Makino H; Chan JC
    Nephrol Dial Transplant; 2016 Mar; 31(3):447-54. PubMed ID: 26152402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Systolic Blood Pressure and Cardiovascular Inpatient Cost Moderated by Peer-Support Intervention Among Adult Patients With Type 2 Diabetes: A 2-Cohort Study.
    Yu D; Cai Y; Graffy J; Holman D; Zhao Z; Simmons D
    Can J Diabetes; 2021 Mar; 45(2):179-185.e1. PubMed ID: 33046400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetes.
    Hermans MP; Ahn SA; Rousseau MF
    J Diabetes Complications; 2012; 26(3):187-94. PubMed ID: 22521319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
    Yew SQ; Chia YC; Theodorakis M
    Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
    McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
    Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
    Mancia G; Facchetti R; Parati G; Zanchetti A
    Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease.
    Kawai T; Ohishi M; Ito N; Onishi M; Takeya Y; Yamamoto K; Kamide K; Rakugi H
    J Hypertens; 2013 Jul; 31(7):1387-95; discussion 1395. PubMed ID: 24006037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: A systematic review and meta-analysis.
    Chiriacò M; Pateras K; Virdis A; Charakida M; Kyriakopoulou D; Nannipieri M; Emdin M; Tsioufis K; Taddei S; Masi S; Georgiopoulos G
    Diabetes Obes Metab; 2019 Dec; 21(12):2587-2598. PubMed ID: 31282073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Systolic and Diastolic Blood Pressure Variability Is Correlated with the Occurrence of Peripheral Arterial Disease in the First Decade following a Diagnosis of Type 2 Diabetes Mellitus: A New Biomarker from Old Measurement.
    Yeh CH; Yu HC; Huang TY; Huang PF; Wang YC; Chen TP; Yin SY
    Biomed Res Int; 2016; 2016():9872945. PubMed ID: 27830155
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
    Herath HM; Weerarathna TP; Umesha D
    Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of diabetic renal function impairment in the first decade after diagnosed of diabetes mellitus is correlated with high variability of visit-to-visit systolic and diastolic blood pressure: a case control study.
    Yeh CH; Yu HC; Huang TY; Huang PF; Wang YC; Chen TP; Yin SY
    BMC Nephrol; 2017 Mar; 18(1):99. PubMed ID: 28330451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes.
    Ciardullo S; Muraca E; Cannistraci R; Manzoni G; Perra S; Bianconi E; Oltolini A; Zerbini F; Grassi G; Mancia G; Lattuada G; Perseghin G
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1494-1500. PubMed ID: 33810954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.